| Xiaodi Yu, | |
|
6787 Market St # 101, Upper Darby, PA 19082-1848 | |
| (610) 352-8000 | |
| Not Available |
| Full Name | Xiaodi Yu |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 6787 Market St # 101, Upper Darby, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861143240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | SP025108 (Pennsylvania) | Primary |
| Entity Name | Everest Medical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104878339 PECOS PAC ID: 1658382908 Enrollment ID: O20060526000013 |
News Archive
Researchers have found that patients with different types of attention-deficit/hyperactivity disorder (ADHD) have impairments in unique brain systems, indicating that there may not be a one-size-fits-all explanation for the cause of the disorder.
A new study of children's hospitals nationwide has found them underequipped to handle a major surge of patients in the event of a pandemic, and urges health care institutions and government agencies to immediately review emergency preparedness plans as flu season approaches.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, announced today that the New Drug Application (NDA) for EXPAREL™, a long-acting bupivacaine for postsurgical pain management, has been accepted for filing by the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
| Entity Name | Everest Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497113666 PECOS PAC ID: 0345549267 Enrollment ID: O20160427002301 |
News Archive
Researchers have found that patients with different types of attention-deficit/hyperactivity disorder (ADHD) have impairments in unique brain systems, indicating that there may not be a one-size-fits-all explanation for the cause of the disorder.
A new study of children's hospitals nationwide has found them underequipped to handle a major surge of patients in the event of a pandemic, and urges health care institutions and government agencies to immediately review emergency preparedness plans as flu season approaches.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, announced today that the New Drug Application (NDA) for EXPAREL™, a long-acting bupivacaine for postsurgical pain management, has been accepted for filing by the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Xiaodi Yu, 1401 Gentlemens Way, Dresher, PA 19025-1031 Ph: (215) 280-8687 | Xiaodi Yu, 6787 Market St # 101, Upper Darby, PA 19082-1848 Ph: (610) 352-8000 |
News Archive
Researchers have found that patients with different types of attention-deficit/hyperactivity disorder (ADHD) have impairments in unique brain systems, indicating that there may not be a one-size-fits-all explanation for the cause of the disorder.
A new study of children's hospitals nationwide has found them underequipped to handle a major surge of patients in the event of a pandemic, and urges health care institutions and government agencies to immediately review emergency preparedness plans as flu season approaches.
AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, announced today that the New Drug Application (NDA) for EXPAREL™, a long-acting bupivacaine for postsurgical pain management, has been accepted for filing by the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
Ms. Nichole P Turner, CRNP Family Medicine Medicare: Medicare Enrolled Practice Location: 120 Summit Ave, Upper Darby, PA 19082 Phone: 267-679-2347 | |
Dr. Loretta Brown, D.O Family Medicine Medicare: Medicare Enrolled Practice Location: 48 Garrrett Road, Successful Aging Care Inc., Upper Darby, PA 19082 Phone: 267-701-1791 | |
Dr. Nghia T. Phan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6800 Market St, Suite # 2h, Upper Darby, PA 19082 Phone: 215-468-5198 Fax: 610-734-7511 | |
Dr. Orlando Zoleta Maloles Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 339 Long Ln, Upper Darby, PA 19082 Phone: 610-734-1198 Fax: 610-734-2328 | |
Khanh Che, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7140 Chestnut Street, Upper Darby, PA 19082 Phone: 610-352-3384 Fax: 610-352-5615 | |
Mr. Abenet Bonger Beyene, NURSE PRACTITIONER Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 126 N Cedar Ln, Upper Darby, PA 19082 Phone: 484-784-8145 |